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ABSTRACT
To ensure accurate and rapid protein synthesis,
nearby and distantly located functional regions of
the ribosome must dynamically communicate and
coordinate with one another through a series of
information exchange networks. The ribosome is
»2/3 rRNA and information should pass mostly
through this medium. Here, two viable mutants
located in the peptidyltransferase center (PTC) of
yeast ribosomes were created using a yeast genetic
system that enables stable production of ribosomes
containing only mutant rRNAs. The specific mutants
were C2820U (Escherichia coli C2452) and )2922C
(E. coli U2554). Biochemical and genetic analyses of
these mutants suggest that they may trap the PTC in
the ‘open’ or aa-tRNA bound conformation, decrea-
sing peptidyl-tRNA binding. We suggest that these
structural changes are manifested at the biological
level by affecting large ribosomal subunit biogen-
esis, ribosomal subunit joining during initiation,
susceptibility/resistance to peptidyltransferase inhi-
bitors, and the ability of ribosomes to properly
decode termination codons. These studies also add
to our understanding of how information is trans-
mitted both locally and over long distances through
allosteric networks of rRNA–rRNA and rRNA–protein
interactions.
INTRODUCTION
The ribosome is a complex nanomachine that accurately
converts genetically encoded information into proteins.
Given its central role in the life of the cell, the ribosome
was a focus of intense study early in the modern age of
biochemistry and molecular biology (1). Early chemical
analyses revealed that it was mostly composed of RNA,
and later biochemical studies suggested that its core
functions were RNA mediated (2), a view that has been
more recently conﬁrmed by the availability of atomic
resolution X-ray crystal structures (3–6). These structures
have engendered a renaissance in the ﬁeld, providing  3D
context to heretofore  2D rRNA interaction maps, and
frameworks upon which some of the dynamic features of
the ribosome can be computationally simulated (7,8).
The ribosome is extremely complex and translation is a
highly dynamic process. Diﬀerent regions of the molecule
must coordinate their functions with one another so as to
assume the proper conformational states in order to
interact with diverse sets of ligands through diﬀerent
stages of the translational program. In addition to X-ray
crystallographic, cryo-electron microscopy and molecular
dynamics modeling, other approaches are currently being
used to understand the dynamics of protein translation.
For example, FRET-based approaches provide means to
measure changes in distance between various structural
elements, providing time resolved views of the moving
parts of the machine (9). Chemical footprinting methods
allow changes in the sites of interaction between rRNA
bases and transacting factors to be mapped over time (10).
Combined molecular genetic and biochemical approaches
have also been instrumental in understanding ribosome
dynamics, revealing such aspects as the kinetic parameters
governing translation (11), the role of tRNA conforma-
tion in ensuring translational ﬁdelity (12), and potential
long range information conduits through the ribosome
(13–16).
To ensure that cells are able to synthesize the large
quantities of ribosomes required for protein synthesis (17),
genomes contain multiple copies of the genes encoding
rRNAs, and they are transcribed separately from genes
encoding proteins in eukaryotes. This has complicated
genetic and biochemical analyses of mutant rRNAs.
In prokaryotes, this problem has been bypassed by
expressing and purifying aptamer-tagged rRNAs (13,18),
by reconstituting ribosomes using synthetic mutant
rRNAs, and by synthesizing RNA/DNA hybrid rRNAs
(19–23). Unfortunately, similar approaches have not been
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strategy used to confront these obstacles has been the
construction of Escherichia coli and yeast strains lacking
chromosomal copies of rDNA genes, allowing episomal
expression of pure populations of ribosomes containing
mutant rRNAs (24,25). The current study was founded on
a previously described method that was used to construct
yeast strains stably expressing only mutant rRNAs (15).
Here, an improvement of this method was employed to
generate rRNA mutants in the peptidyltransferase center
(PTC). A complementary series of biochemical and genetic
analyses were employed to address questions regarding
how the ribosome structure inﬂuences its function. These
include how structural changes aﬀect ribosome biogenesis
and subunit joining during initiation; how they can
confer susceptibility/resistance to peptidyltransferase inhi-
bitors; and how ribosomes to properly decode termination
codons. In addition, the ribosome is a complex and
dynamic nanomachine that must coordinate a signiﬁcant
series of functions among a number of diﬀerent centers.
This engenders questions regarding how rRNA–rRNA
and rRNA–protein interactions work to ensure accurate
local and long-distance information exchange among its
many parts. The studies described in the current work
begin to address these questions by focusing on two rRNA
mutants located in the PTC of the yeast ribosome,
speciﬁcally C2820U and  2922C (equivalent to C2452U
and U2554C in E. coli, see Table 1).
MATERIALS AND METHODS
Strains, media, reagents, genetic, andmolecular methods
Escherichia coli DH5a strain was used to amplify
plasmids and all experiments were performed in yeast
strain JD1314 (MATa ade2–1 ura3–1 trp1–1 his3–11
leu2–3, 112 can1–100 DrDNA::his3::hisG [L-A HN
M1]+pNOY353). This strain is derived from NOY1049
(26), kindly provided by Dr M. Nomura. Yeast media
were prepared as described (27), and galactose media
contained 2% galactose instead of glucose. Drug concen-
trations in yeast media were as follows: doxycycline, 10mg/
ml; hygromycin B, 300mg/ml; anisomycin, 20mg/ml. Yeast
rRNA-containing plasmids were previously described
(15,28). pNOY353 (pGAL) is a TRP1 selectable, 2m
plasmid containing a 5S rRNA gene under control of
its endogenous RNA polymerase III promoter, and a 35S
pre-rRNA operon under control of the RNA polymerase
II driven GAL7 promoter. pJD694 (pTET) is a URA3
selectable, 2m plasmid containing a 5S rRNA gene under
control of its endogenous RNA polymerase III promoter,
and a 35S pre-rRNA operon under control of the RNA
polymerase II driven, tetracycline (doxycycline) repressi-
ble TET promoter. pJD180.Trp is a TRP1 selectable,
2m vector containing an entire RDN1 repeat in which both
the 35S pre-rRNA operon and 5S rRNA gene are
transcribed from their native RNA polymerase I and III
promoters, respectively. Mutations in rDNA encoding
regions of pJD694 (pTET) and pJD180.TRP were
introduced by oligonucleotide site-directed mutagenesis
using DNA oligonucleotides from IDT DNA Technolo-
gies (Coralville, IA) and the QuikChange II XL Site-
Directed Mutagenesis Kit (Stratagene). Oligonucleotide
design and reaction conditions were as recommended by
the manufacturer. All mutations were conﬁrmed by
sequencing. Transformations of yeast strain JD1314
were performed according to alkaline cation protocol
(29). Yeast strains expressing mutations in rRNA were
selected as previously described (15). To switch rRNA
transcription from RNA polymerase II to RNA poly-
merase I driven transcription of 35S pre-rRNA, yeast
strains expressing wild-type or mutant rRNA from
pTET were transformed with pJD180. Trp-based plasmids
containing either wild-type sequence or the speciﬁed
mutations in the 25S rDNA gene. Transformants were
initially selected on H  Trp  Ura medium, followed by
two passages of replica plating onto H  Trp+5-FOA
thus identifying cells in which 35S pre-rRNA was only
expressed from the RNA polymerase I promoter. Direct
reverse transcriptase primer extension sequence analysis of
rRNAs extracted from puriﬁed ribosomes was performed
as previously described (15).
Genetic assays
General growth defects were monitored by dilution spot
assay in which 2.5ml of ﬁve sets of 10-fold dilutions were
spotted on the YPAD medium yielding a range of spots
from 10
5 to 10
1 CFU/spot. Plates were incubated at 188C,
308C, and 378C. For drug disc assays, 10ml solutions
containing 7.8mg/ml sparsomycin, 2mg/ml anisomycin or
250mg/ml paromomycin were applied to 6mm diameter
ﬁlter paper discs and air dried. Overnight yeast cultures
were diluted to OD595=0.3, 300ml of the resulting
suspensions were plated onto YPAD medium, the drug-
saturated discs were applied, plates were incubated
at 308C for 3 days and the diameters of growth inhibi-
tion zones were measured. A minimum of at least two
Table 1. Comparative numbering for bases of large subunit rRNA
discussed in the current study
Saccharomyces cerevisiae Escherichia coli Haloarcula marismortui
G2621
  G2252 G2285
A2778 A2407 U2445
A2779 U2408 G2446
G2814
  G2446 G2481
A2818
  A2450 A2485
A2819
  A2451 A2486
C2820
 (v) C2452 C2487
G2822 G2454 G2489
U2825  2457 U2492
U2828 U2460 U2495
G2862 G2494 G2529
A2863 G2495 C2530
C2866 C2498 C2533
G2921 G2553 G2588
 2922
 (v) U2554 U2589
U2948
   2580 U2615
A2971
  A2602 A2637
A3047 C2681 C2718
A3048 A2682 A2719
Asterisk denote bases of yeast 25S rRNA targeted for mutagenesis.
Bases marked with (v) yielded viable mutants.
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suppress a UAA nonsense codon utilized the pYDL-UAA
dual luciferase reporter constructs as previously described
(30). At least 9–12 readings were taken for each sample
until the data were normally distributed to enable
statistical analyses both within and between experiments
(31). The [PSI
+] prion form of yeast eukaryotic release
factor 3 (eRF3) was cured after several passages of cells
on YPAD media containing 5mg/ml of guanidinium
hydrochloride (32). Cured strains were transformed with
the pYDL-UAA reporter constructs and analyzed as
described above.
Aminoacyl-tRNA bindingassays, polysome profiles, rRNA
chemical protection, andmolecular visualization
Yeast phenylalanyl-tRNA was purchased from Sigma
(St Louis, MO), charged with [
14C]-Phe or Ac-[
14C]-Phe
and puriﬁed by HPLC as previously described (33).
Ribosomes were isolated from isogenic wild-type and
mutant cells, and tRNA-binding studies were carried out
as previously described (33). Lysates of cycloheximide
arrested yeast cells were sedimented through 7–47%
sucrose gradients and polysome proﬁles were determined
by monitoring A254nm as previously described (34).
Puriﬁed ribosomes were pre-incubated with 100-fold
molar excess of anisomycin or buﬀer, chemically probed
with dimethylsulphate (DMS), kethoxal or carbodiimide
metho-p-toluenesulfonate (CMCT), followed by reverse
transcriptase primer extension analyses of modiﬁed
rRNAs as previously described (35) with the modiﬁcation
that reactions were performed at 308C instead of 378C.
The following primers were used: 25-4 (50-TAAAGGAT
CGATAGGCC-30); 25-5 (50-GTCGCTATGAACGCTT
G-30); 25-6 (50-AACCTGTCTCACGACGG-30); 25-7
(50-CCTGATCAGACAGCCGC-30); 25-8 (50-GACGCC
TTATTCGTATCCA-30); 25-10 (50-GGTATGATAGGA
AGAGC-30); and 25-11 (50-CCTCTATGTCTCTTCAC-
30). Primer extensions from 25-4 allowed analyses span-
ning helices 83–87; 25-5 covered bases in the PTC and in
helixes 86–88; 25-6 enabled analysis of helices 89–93; 25-7
covered bases from helices 93 to 95; 25-8 covered helixes
96–97, 25-10 covered helix 89 of 25S rRNA, and 25-11
covered helices 73–74 of 25S rRNA. X-ray crystal
structures of the Haloarcula marismortui 50S ribosomal
subunit complexed with either anisomycin (PDB IK73)
(36) or with CCA-Phe (PDB 1VQ6) (8) were visualized
using PyMOL (DeLano Scientiﬁc LLC).
RESULTS
Generation ofrRNA mutants in thePTC and theA-loop
Previously, we described a genetic protocol enabling
construction of yeast cells stably expressing only mutant
rRNA alleles (15). In the ﬁrst phase of the current study,
this method was applied to selected bases of 25S rRNA.
Bases were chosen for mutagenesis because of their
locations in or near important structural elements of
the PTC and because mutations at these positions had
been previously shown to promote altered sensitivities
to antibiotics in various prokaryotes and archae (36).
Yeast 25S rRNA bases targeted for mutagenesis, and
their corresponding 23S rRNA bases in E. coli and
H. marismortui are shown in Figure 1A and B and Table 1.
For consistency, the yeast numbering system is primarily
used throughout this report. Mutagenesis of G2621
(the ‘P-loop’), G2814, A2818, A2819, U2947, and A2971
(all in the core of the PTC) to any of the three alternative
bases were inviable, supporting the prior observation of a
quality-control mechanism capable of detecting and
eliminating the defective rRNAs in ribosomes (37). Two
alleles did prove to be viable: cytosine 2820 to uracil
(C2820U), and pseudouridine 2922 to cytosine ( 2922C)
(Figure 1A and B). The C2820A mutant was also viable,
but only in the presence of high concentrations of
anisomycin, i.e. it was anisomycin-dependent for growth
(Figure 1D).
In the course of these studies, it was observed that cells
expressing wild-type rRNA from either the pGAL or
pTET plasmids (RNA polymerase II promoters) were
intrinsically temperature sensitive and grew at signiﬁcantly
slower rates than cells in which the wild-type rRNA was
transcribed from the native RNA polymerase I promoter
(e.g. the pJD180 series of plasmids). This is consistent with
the observation that transcription of 35S pre-rRNA
by RNA polymerase II is suboptimal for cell growth
and viability, perhaps introducing an unwanted set of
artifacts into the system (38–40). To address this, cells
expressing either the wild-type rRNA sequence, or those
expressing only the C2820U or  2922C forms of 25S
rRNA using the pTET system (RNA Pol II) were
transformed with plasmids in which 35S pre-rRNA is
transcribed from the native RNA polymerase I promoter
(pJD180.Trp). Standard plasmid shuﬄe methods (41)
were then used to obtain cells expressing either wild-type
or mutant 35S rRNAs. These cells were signiﬁcantly more
robust (data not shown).
Improvement of the genetic system enabled more ﬁne
scale analyses of the eﬀects of the two mutants on cell
growth. C2820U conferred strong temperature (378C) and
cold (188C) sensitive growth defects (Figure 1C) and
resistance to anisomycin (Figure 1D), a competitive
inhibitor of aa-tRNA binding (42). The C2820A mutant
was also viable, but only in the presence of high concen-
trations of anisomycin, i.e. it was anisomycin-dependent for
growth (Figure 1D). Even under these conditions however,
it did not grow well, and we were unable to perform
subsequent analyses with this allele. C2820G was inviable.
 2922C, located at the tip of helix 92 (the A-loop) resulted
in slightly decreased growth at 378C and cold sensitivity
(Figure 1C). The  2922A and  2922G promoted mutants
were inviable as the sole forms of 25S rRNA.
The C2820Uand )2922C 25SrRNA mutants
affectlarge subunit biogenesis
Mutations of 60S components often promote large
ribosomal subunit biogenesis defects. Sucrose density
gradient analysis of cycloheximide arrested S30 cytosolic
preparations (polysome proﬁles) revealed signiﬁcant
diﬀerences between wild-type and mutant rRNAs
(Figure 1E). The 60S/40S ratio >1 observed when
Nucleic Acids Research, 2008, Vol. 36, No. 5 1499wild-type rRNA was episomally expressed from the native
RNA polymerase I promoter was similar to the pattern
observed using ‘wild-type’ cells where rRNAs are tran-
scribed from the native, chromosomal context. Episomal
expression of the C2820U and  2922C mutants using this
system revealed 60S/40S ratios of <1, decreased 80S peak
heights, and the presence of half-mer polysomes. These
observations are suggestive of defects in 60S subunit
biogenesis and in translation initiation. As discussed
below, this defect may be occurring at the stage of 60S
joining with the 43S pre-initiation complex.
The effects ofC2820U on rRNA structure arelocally
confined, while )2922Caffects bothlocal and distant
rRNA structures
Given the large subunit-speciﬁc eﬀects of the mutants,
chemical protection methods were used to probe for
eﬀects of the mutants on 25S rRNA structure. Ribosomes
puriﬁed from wild-type and mutant cells were pre-
incubated with 100-fold molar excess of anisomycin or in
buﬀer alone, and subsequently probed for structural
changes using three base-speciﬁc solvent accessible rea-
gents: DMS, kethoxal, and CMCT. rRNAs were extracted,
and modiﬁed bases were identiﬁed by primer extension
using reverse transcriptase to detect methylation at the N3
position of uridines and the N1 position of guanosines
(CMCT), at the N1 and N2 positions of guanosines
(kethoxal), and at the N1 position of adenosines and N3
position of cytidines (DMS) (43). Reverse transcriptase
cannot use modiﬁed bases as templates for cDNA
synthesis, resulting in strong stops one base 50 of the site
of modiﬁcation. The reverse transcriptase reactions were
also scored for changes in ‘in-line cleavage’ patterns
as caused by alterations in the ﬂexibility of bases in
GGA AA
G
A
A
G
A C
C
C
U
G UU
G
A
G
C
U
U
G
A
C
U
C
U
A
G
U
U
U
G
A
CG
U
C
A
G
G
U
G
G G
G
A
G
U
U U G
G
C
U
G
G G G
C
G
G
CA
C A
U
C
U
G
U
U
A
A
A
C G A
U
A
A
C
G
C
A
G
A
U G U CC
U
A
A
G
G
G
G
GC
C
C
C
U
U GAU
UUUGAUUU
U CA
G
U
G U G A A U A C A A
A
C
C
A
U
G
A A
A
G
U
G
U
G G
C
C
U
A
U C G
A
U
C C
U
U
U
A
GU
C C
C
U
C
G
G
A A U
U
U
G
A
G
G
C
U
A
G
A
G
G
U
G C C A
G
A
A A
A
G
U
U A
C C
A
C
A
G
G
G A U
A
A
C
U
G
G C UUG U GGCAGU
C A A
GCG U
U
C
A
U A G C
G A C
A U U G C U U
U U
U G A U
U
C
U
U
C
G
A
U
G U C
G
G
C
U
C
U
U
C
C
U
AUCA UA C C G A A G C
A
G
A A U U C G G U
A A
G C G U
U
G
G
A
U
U
G U
C
A
C
C
C
A C
U
A
A
U A
G
G
G
A A
C G
U
G A
G
C
U
G
G G U U U
A
G
A
C
C
G
U
C
G U
G
A
G
A
C
A
G
G
U
U
A
G
U
U
U U
A C
C C
2400
2600
2650
2750 2800
2850
2900
2950
H73
H75
H74
H
8
0 H82
H83
H86
H87
H88
H89
H90
H91
H92
H93
Ψ2922
U2947
C2820
G2621
G2814
A2818
A2819
A2971 CCA-Phe
30°C3 7 °C 
WT 
C2820U 
Ψ2922C
Anisomycin 
20 µg/ml
C2820U
C2820A
C2820G
WT
WT C2820U Ψ2922C
40S
60S
80S
Poly
Half-mers
A B
C
D
E
18°C
ψ
Figure 1. Generation and preliminary characterization of mutants in the yeast peptidyltransferase center (PTC). (A) 2D map showing locations of
bases in the PTC targeted for mutagenesis. All alleles of bases boxed in black with red diagonal slashes were inviable as the sole forms of 25S rRNA.
Bases for which viable mutants were obtained are boxed in green (C2820U) and blue ( 2922C). This color scheme is used throughout the ﬁgures.
(B) 3D stereoscopic view of the mutants mapped in panel A based on the Haloarcula marismortui atomic resolution 50S structure (8). The location of
Phe-ACC in the A-site of the PTC is shown in red. (C) Dilution spot assays of the eﬀects of the two viable mutants expressed as the sole forms
of 25S rRNA from the native RNA polymerase I promoter on cell growth at optimum (308C), high (378C), and low (188C) temperatures.
(D) Growth phenotypes of C2820 mutants in the presence of anisomycin. Primary transformants were grown on  trp medium containing 5-FOA
to select against wild-type rRNA, hygromycin to select for mutant rRNA, and 20mg/ml anisomycin. Note that C2820A was only viable in the
presence of anisomycin. (E) 60S ribosomal subunit biogenesis and polysome defects caused by expression of C2820U or  2922C mutations
transcribed from the native RNA polymerase I promoter. Cytoplasmic extracts from isogenic strains were separated through continuous 7–47%
sucrose gradients in an SW41 rotor at 40,000 r.p.m. for 240min at 48C, and analyzed by continuous monitoring of A254. Positions of 40S, 60S, 80S,
polysomes, and half-mers are indicated.
1500 Nucleic Acids Research, 2008, Vol. 36, No. 5single-stranded regions of RNA, which can aﬀect the
frequency of spontaneous cleavage of an RNA phospho-
diester linkage via an internal nucleophillic attack by
the 20 oxygen on the adjacent phosphorous center (44).
These appear as increased or decreased band intensities
at the site of the cleavage due to runoﬀ of the enzyme.
The primers used (see Materials and Methods) were
designed to probe functional regions of domain V
(including the A-site and P-site loops, the PTC, and
the helices adjacent to these structures, i.e. helices 73, 74,
89–93) and helices 94–96.
The results of these experiments are shown in Figure 2.
In general, the eﬀects of the C2820U mutant were
localized to the vicinity of the lesion in 25S rRNA at
the base of helix 89. Speciﬁcally, this mutation promoted
hyperprotection (i.e. decreased solvent accessibility) of
G2862 to chemical attack (Figure 2A and B, open
triangle). G2822 and U2825 were also hyperprotected
both in the presence and absence of chemical agent,
a pattern that is indicative of in-line cleavage (indicated
by arrows in Figure 2A and B). The increased protection
of U2825 from in-line cleavage and of G2862 from
chemical attack suggests that this base pair is strengthened
by the C2820U mutation.
The eﬀects of the  2922C mutation on 25S rRNA
structure were more widely distributed and generally led to
increased exposure of aﬀected bases to solvent (Figure 2A
and C). At the site of the mutation, the cytosine at position
2922 became deprotected. Locally, the in-line cleavage
patterns of two bases, G2921 (decreased reactivity) and
U2948 (increased reactivity) were also observed. The
 2922C mutation also speciﬁcally promoted deprotection
of two clusters of adjacent adenosine residues in distal
regions of 25S rRNA. In the loop of helix 88 (the E-site),
this mutation promoted deprotection of A2778 and A2779.
Similarly, A3047 and A3048, which map to a bulge in helix
96 were also deprotected.
Comparison of rRNAs in the presence or absence of
anisomycin was also informative. In wild-type (and
 2922C) cells, addition of anisomycin resulted in protec-
tion of C2820 from chemical attack as compared to the
no-drug controls (Figure 2C, indicated by white versus
black triangles, respectively). These data are consistent
with a prior study showing that anisomycin protected this
cytosine in the yeast 25S rRNA from chemical attack (45).
In contrast, anisomycin did not alter the protection
pattern at the C2820U mutant (indicated by circles
in Figure 2C), suggesting that the drug does not interact
with this base. This is consistent with studies of
anisomycin resistant Halobacterium and Thermophilus
species containing C to U mutations at this position
(36,45).
C2820Uand )2922C affecttRNA binding
to theribosomal P-site
Changes in rRNA structure in the vicinity of the PTC
can aﬀect tRNA binding. To test for such eﬀects,
tRNA-binding assays were performed under equilibrium
conditions. To monitor tRNA binding to the A-site,
non-salt washed ribosomes were ﬁrst incubated with
excess unlabeled deacylated tRNA to block non-speciﬁc
binding sites, and subsequently with increasing concentra-
tions of [
14C] Phe-tRNA (aa-tRNA). These conditions
result in eEF1A assisted binding of labeled aa-tRNA to
the A-site. These studies indicated that neither of the
mutants aﬀected A-site tRNA binding (Figure 3A and B).
To monitor binding to the P-site, puriﬁed ribosomes were
incubated in increasing concentrations of acetylated [
14C]
Phe-tRNA (Ac-aa-tRNA), which speciﬁcally has high
aﬃnity for the P-site. These experiments demonstrated
that the mutants promoted more than two-fold increases
in the dissociation constants (Kd) for tRNA at the
ribosomal P-site (Figure 3C and D).
The C2820Uand )2922C mutants promote hypersensitivity
tosparsomycin and paromomycin and affecttermination
codonrecognition inthe presence ofthe [PSI
+] prion
tRNA-binding defects are often accompanied by hyper-
sensitivity to translational inhibitors. Filter disc assays
conﬁrmed that C2820U was resistant to anisomycin as
indicated by the lack of a zone of growth inhibition
around the anisomycin disc (Figure 4A). Sparsomycin
interacts with the P-site and aﬀects interactions between
the ribosome and the peptidyl-tRNA (36,46). Consistent
with the changes in Kd values for Ac-aa-tRNA, increases
in the zones of growth inhibition around the sparsomycin
discs showed that both mutants were hypersensitive to
this drug relative to wild-type cells (Figure 4A). With
regard to the  2922C mutant, this is consistent with
a prior report showing that deletion of snr10, the snoRNA
that directs pseudouridylation of U2922 also promoted
sparsomycin sensitivity (47). Although paromomycin is
an aminoglycoside antibiotic that interacts with the
decoding center in the small subunit (48), mutations of
large subunit rRNAs and proteins have been previously
shown to aﬀect sensitivity to this drug (49–51). The very
large growth inhibition zones promoted by paromomycin
indicated that both mutants were hypersensitive to this
antibiotic (Figure 4A), also consistent with paromomycin
hypersensitivity of the snr10D mutant (52). Paromomycin
stimulates termination suppression in yeast (53). Thus,
the eﬀects of the two mutants on the ability of ribosomes
to recognize the UAA termination codon was assayed
using a previously described dual-luciferase reporter
system (54). The results demonstrated that the C2820U
mutant slightly stimulated translational suppression of the
UAA codon, while  2922C was approximately two-fold
more accurate (Figure 4B). The actual rates of UAA
suppression originally observed in wild-type cells (4.5%)
was unusually high however, commensurate with levels
normally associated with the presence of [PSI
+] (30), the
prion form of yeast eRF3 (55). To test this hypothesis
and to examine the eﬀects of termination suppression in
the absence of the prion, cells were cured of [PSI
+]b y
serial passage in the presence of guanidinium hydrochlor-
ide (32). In wild-type cells, this treatment returned rates
of UAA suppression down to normal levels (0.27%)
(Figure 4B, see inset). Interestingly, the mutants no longer
aﬀected termination suppression when cured of [PSI
+].
Nucleic Acids Research, 2008, Vol. 36, No. 5 1501This suggests that the mutants only aﬀect UAA recogni-
tion when eRF3 availability is limited.
DISCUSSION
The current study employed a genetic method to create
rRNA mutants targeted to the PTC. Almost all of the
mutants were inviable as the sole forms of large subunit
rRNA in agreement with prior studies in E. coli (see Refs.
56–59). Unlike bacteria, where an in vitro ribosome
reconstitution (60), and the ability to aﬃnity purify
tagged ribosomes (59,61) has enabled biochemical char-
acterization of such inviable mutants, similar studies
of eukaryotic ribosomes are hampered by the lack of
these tools. Despite these limitations, two viable mutants,
C2820U and  2922C, were generated in yeast and
characterized using biophysical, biochemical and genetic
methods. This discussion focuses on how the data so
gathered add to our understanding of how the structure of
the ribosome inﬂuences its function.
Local changes inthe PTC
As noted above, the ribosome has a many functional
centers and moving parts whose activities must be
coordinated throughout the diﬀerent phases of transla-
tion. Cryo-electron microscopy reconstructions have
revealed large-scale rearrangements between and within
both large and small subunits during diﬀerent phases
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Figure 2. rRNA structural analyses. (A) Structure probing of wild-type and mutant ribosomes through helices 88–97. Sequencing ladders (left) and
primer extensions were generated with AMV reverse transcriptase using rRNAs isolated from puriﬁed ribosomes. Along the bottom, U indicates
untreated samples; D denotes ribosomes treated in vitro with dimethylsulphate (DMS); K is ribosomes treated in vitro with kethoxal; C designates
ribosomes treated in vitro with carbodiimide metho-p-toluenesulfonate (CMCT). Individual nucleotide positions of bases in mutant samples showing
altered protection patterns are indicated along the right side. Enhanced chemical protection relative to wild-type rRNA are indicated by white
triangles, and bases showing relative deprotection are indicated by black triangles. Note that base modiﬁcation inhibits recognition by reverse
transcriptase, resulting in strong stops one nucleotide 50 of the chemically modiﬁed base. Bases with altered in line rRNA cleavage patterns are
indicated by black arrows. Note that in-line cleavage results in transcriptional runoﬀ by reverse transcriptase producing an intense band at the siteo f
cleavage. (B) 2D mapping of data shown in panel A. Sites of the mutations are boxed as in Figure 1A. Labeling follows conventions described in
Panel A. PTC denotes the peptidyltransferase center. Helices are numbered, the locations of every 50th base are numbered from the 50 end of yeast
25S rRNA, and every 10th base is indicated by tick marks. (C) Eﬀects of anisomycin on chemical modiﬁcation. As indicated, ribosomes were pre-
incubated in 100-fold molar excess of anisomycin, or without drug. Circles denote CMCT reactivity of U2820 in the C2820U mutant. Sequence
ladder of C2820U mutant is shown at right.
1502 Nucleic Acids Research, 2008, Vol. 36, No. 5of translation, suggesting pathways for signal transduc-
tion over long distances (62). The highly conserved nature
of the rRNA residues examined and identiﬁed in this study
allows them to be mapped to atomic-resolution ribosome
structures with a relatively high degree of conﬁdence.
Thus, the mutants and bases with altered reactivity were
mapped to the H. marismortui 50S atomic resolution
structure (Figure 5). The rationales for using this structure
are (i) it represents the highest resolution large subunit
structure available and (ii) both the bases that were
mutagenized and those whose protection patterns were
altered are highly conserved and are found in structurally
conserved, core regions of the ribosome.
Figure 5A shows a ‘big picture’ view of where the bases
identiﬁed in Figure 2 map to the large subunit 3D
structure. A close-up view shows that both the C2820U
and  2922C mutants aﬀected local rRNA structures
at the PTC proximal ends of the helix 89 and the helix
90–92 structure, respectively (Figure 5B). These form the
two sides of the aa-tRNA accommodation corridor at
the A-site of the PTC (7). C2820U promoted hyperprotec-
tion and/or decreased ﬂexibility of the helix 89 side of
this structure by stabilizing the U2825–G2862 base pair,
and restricting the ﬂexibility of G2822. In contrast, the
 2922C mutant resulted in deprotection/altered ﬂexibility
of key residues on the other side of the corridor, G2921
and U2948. Consistent with the induced ﬁt model of
peptidyltransfer (8), we suggest that the combination of
the weak base pairing potential at the base of helix 89 in
combination with the inherent ﬂexibility at the base of the
helix 90–92 structure work together to properly conﬁgure
the A-site region of the PTC depending on tRNA
occupancy status. We hypothesize that these mutants
have shifted the dynamic nature of this region toward
the conformation favored by the presence of aa-tRNA in
the A-site, i.e. the ‘open’ conformation of the A-site
crevice (8,63,64).
To account for the speciﬁc eﬀects observed on binding
of Ac-aa-tRNA to the P-site but not of aa-tRNA to the
A-site, it is important to note that the assay for A-site
binding was performed in excess of cold deacylated tRNA
because the aa-tRNA alone can bind equally well to either
site. Thus, full occupancy of both the A- and P-sites in
the PTC in this assay could help to stabilize and maintain
the labeled aa-tRNA in the correct orientation, resulting
in no apparent eﬀects on aa-tRNA binding. In contrast,
because of its highly speciﬁc aﬃnity for P-site, only
Ac-[
14C]Phe-tRNA is used in the P-site binding assay.
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Figure 3. tRNA-binding studies. Binding of aminoacyl-tRNA to the ribosomal A-site (panels A and B), or of acetylated-aa-tRNA to the P-site was
carried out in 30ml reaction mixtures containing 25 pmol of ribosomes primed with 25mg of poly(U). For A-site binding assays, non-salt washed
ribosomes were preincubated with 10mg uncharged tRNAs at 308C for 30min to insure full occupation of P-sites by uncharged tRNA. Increasing
amounts (1–128pmol) of [
14C]-Phe-tRNA were added, and incubations continued for 20min at 308C to allow formation of [
14C]-Phe-
tRNA 80S poly(U). To monitor P-site binding, salt-washed ribosomes were incubated at 308C for 20min with increasing amounts (1–128pmol) of
Ac-[
14C]-Phe-tRNA. Reaction mixtures were applied onto nitrocellulose membranes, ﬁlters were washed with binding buﬀer, and radioactivity was
measured by scintillation counting. Single site-binding isotherms were ﬁtted to the data (panels A and C) and Kd values (panels B and D) were
calculated using GraphPad Prism 4.
Nucleic Acids Research, 2008, Vol. 36, No. 5 1503With no other tRNAs present to stabilize its interactions
with the ribosome, binding of the Ac-aa-tRNA would be
more sensitive to distortions in the PTC, resulting in the
observed increased Kd’s of the mutants for Ac-aa-tRNA
(Figure 3C and D). Indeed, these mirror actual biological
conditions, where the P-site can be occupied by peptidyl-
tRNA while the A-site is empty, but the A-site is never
occupied by tRNA without the P-site being ﬁlled. This
may explain why both the C2820U and  2922C mutants
were hypersensitive to the P-site speciﬁc antibiotic
sparsomycin (Figure 4A): the eﬀects of these mutants
are most strongly manifested when there is no tRNA
present in the A-site to help stabilize the peptidyl-tRNA.
We also suggest that decreased aﬃnities for peptidyl-
tRNA could be the underlying cause of the 60S subunit
joining defects (Figure 1E), as binding of initiator tRNA
to the P-site without a tRNA in the A-site is a central
event in translation initiation. Lastly, even though a two-
fold change in Kd is only  100 calories, these results
support the notion that small biochemical changes can be
ampliﬁed through a series of physiological events resulting
in signiﬁcant biological eﬀects.
The chemical protection studies performed in the
presence or absence of anisomycin (Figure 2C) conﬁrms
that anisomycin protects C2820 from attack by DMS.
The hydrophobic p-methoxyphenyl group of anisomycin
is inserted into the A-site crevice where it aromatically
stacks with C2820 (E. coli C2452, H. marismortui C2487),
while the nitrogen of its pyrrolidine group hydrogen bonds
with N3 of this base. It is also stabilized by interactions
with additional bases and coordination with a potassium
ion. The C2820U mutation is predicted to eliminate
the hydrogen bond to the pyrrolidine nitrogen atom of
anisomycin (36). Our ﬁnding that anisomycin failed to
change the chemical protection pattern at this site in
the C2820U mutant suggests that anisomycin cannot
interact with uracil in this position, providing empirical
support for this model in a eukaryotic ribosome.
Long-distance information exchange within the
large subunit
Although the concept of allosteric information exchange
within the ribosome has been known since the linkage
between streptomycin and rifampicin mutants were esta-
blished (65), mapping of speciﬁc intraribosomal informa-
tion exchange networks remains a challenge. Figure 5C
shows that the  2922C mutant promoted deprotection of
25S rRNA residues located very far apart from one
another. Speciﬁcally, A2778 and A2779 are located near
the E-site at the tip of the loop of helix 88. This helix is
coaxially stacked with helix 74, which in turn contacts the
PTC where  2922C is located. Also in this region, this
mutation rendered U2948 more susceptible to in-line
cleavage, consistent with the ‘open’ A-site crevice hypoth-
esis. It is also notable that deletion of U2948, or mutating
it to G, C, or A resulted in lethality, suggesting that the
identity of this base is critical. In the H. marismortui
crystal structure, this base interacts directly with K226
(yeast K244), which resides in the central extension of
ribosomal protein L3 (see Figure 5B and C). At the base
of this extension is the major globular domain of L3,
six residues of which make extensive hydrogen bond based
contacts with A3047 and A3048, the other two residues
that were deprotected in the  2922C mutant (Figure 5C
and D). These residues are important because they rest at
the base of helix 95, atop which sits the Sarcin/Ricin loop,
which is involved in elongation factor binding (66). Thus,
even though the tip of helix 88 and the base of helix 95 are
separated by  135A ˚ , the chemical protection analyses
reveal a direct line of communication connecting the
A-, P-, and E-sites with the elongation factor binding
center. These data tie in well with other ﬁndings. For
example, mutation of T54 (which interacts with A3048,
see Figure 5D) to alanine, was identiﬁed as promoting
resistance to anisomycin (33). Another study of the central
extension of ribosomal protein L3 in which K244 resides
showed that this domain of the protein functions
to communicate and coordinate the various steps of
the translation elongation cycle between the PTC and
the elongation factor binding site (67), and to ﬁne tune the
3D geometry of the PTC (68). Additionally, the chemical
reactivity of these two bases were also aﬀected by
mutation of the N-terminal extension of L3, and we
have suggested an allosteric model for how L3 functions
as part of an allosteric switch to communicate the tRNA
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Figure 4. Phenotypic analyses of C2820U and  2922C mutants.
(A) Drug disc assays. Overnight yeast cultures were diluted to
OD595=0.3, and 300ml of the resulting suspensions were plated onto
rich medium. Sterile 0.6cm diameter ﬁlter paper discs were saturated
with the indicated amounts of sparsomycin, anisomycin, paromomycin
or water and placed onto the plates. Cells were incubated at 308C for 3
days and the diameters of growth inhibition zones were monitored.
(B) UAA termination suppression assays. Suppression of a UAA
nonsense codon utilized the pYDL-UAA dual luciferase reporter
constructs as previously described (30,31). The [PSI
+] prion form of
yeast eukaryotic release factor 3 (eRF3) was cured after several
passages of cells on YPAD media containing 5mg/ml of guanidinium
hydrochloride (GuHCL). Cured strains were transformed with the
pYDL-UAA reporter constructs and analyzed as described above.
The insert shows the same data with an expanded Y-axis. Error bars
denote standard error.
1504 Nucleic Acids Research, 2008, Vol. 36, No. 5occupancy status of the PTC to other functional regions of
the ribosome (69). The current study allows us to extend
this long-distance information conduit out to the E-site,
where presumably information pertaining to its occupancy
status by deacylated tRNA can be tied into this network.
In addition, consistent with our studies of helix 38 (15),
the hypersensitivity of the C2820U and  2922C mutants
to paromomycin and the eﬀects of these mutants on
termination codon recognition (albeit only when eRF3 is
limiting due to the presence of the [PSI
+] prion) points to
long-distance communication and coordination of func-
tion between the PTC in the large subunit and the
decoding center in the small subunit.
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